Login
Enter your Progress In Mind Portugal username.
Enter the password that accompanies your username.

Request new password

Home

Progress in Mind Portugal

  • Topics
    • Depression
    • Migraine
    • Schizophrenia
  • Congress highlights
    • EAN 2022
    • AAN 2022
    • AHS 2022
    • AAN 2021
    • AHS 2021
    • IHC 2021
    • SIRS 2019
    • EPA 2019
    • EPA 2018
    • APA 2018
    • ECNP 2017
  • About
  • Podcasts
  • Newsletter signup

Search

Main navigation

  • Home
  • Lundbeck Therapeutic Area Australia
  • Progress in Mind Korea Focus Area
  • Progress in Mind Spain Focus Area
  • 전문가 칼럼
  • 찾아보기

Tools

  • 찾아보기
  • User Profile

User account menu

  • Log in
  • Reset your password
Powered by Drupal

The information on this site is exclusively intented for health care professionals.

Accept Decline

Schizophrenia

Discover the archives of schizophrenia and related articles

  • Depression, Schizophrenia 18 Oct, 2022 Read Time: 5 mins
    Article

    Strategies for precision prescribing in psychiatry

    In a symposium at CINP 2022 entitled ‘Strategies for Precision Prescribing in Psychiatry,’ Prof...
  • Mental Health 04 Oct, 2022 Read Time: 4 mins
    Congress highlights Article

    Benefits of measurement-based care in psychiatry

    Dr Erik Vanderlip (Oregon Health & Science University, USA) was involved in forming the Workgroup...
  • Schizophrenia 07 Sep, 2022 Read Time: 3 mins
    Congress highlights Article

    Interventions to improve real-life functioning

    Accurate assessment of neurocognition and social cognition and personalized cognitive training and...
  • Schizophrenia 25 May, 2022 Read Time: 3 mins
    Congress highlights

    What is happening in the brain during schizophrenia?

    Neuroimaging reveals loss of brain gray matter volume in schizophrenia. New insights into the...
  • Mental Health 03 Mar, 2022 Read Time: 3 mins
    Congress highlights

    Current practice with e-mental health and future standards

    E-mental health is the future for improved mental health delivery at all stages of the patient...
  • Schizophrenia 18 Feb, 2022 Read Time: 3 mins
    Congress highlights Article

    New 2021 guidelines for the treatment of schizophrenia are now available in Japan

    The new evidence-based guidelines for the pharmacological therapy of schizophrenia from the Japanese...
  • Schizophrenia 14 Feb, 2022 Read Time: 2 mins
    Congress highlights

    Can we predict the future of patients with early-episode psychosis?

    The ability to better predict patient outcomes would be highly valuable to clinicians, allowing the...
  • Schizophrenia 08 Feb, 2022 Read Time: 4 mins
    Satellite symposium

    Long-acting therapies could reduce schizophrenia relapse

    Relapse in schizophrenia contributes to a downward spiral in disease progression. The likelihood of...
  • Schizophrenia 06 Dec, 2021 Read Time: 4 mins
    Satellite symposium

    The COVID-19 pandemic and mental health - impact and implications

    One of the goals of the European College of Neuropsychopharmacology (ECNP) is to facilitate the...
  • Depression, Schizophrenia 02 Dec, 2021 Read Time: 5 mins
    Satellite symposium

    Exploring life engagement in major depressive disorder (MDD) and schizophrenia – mechanisms, measurement, and meaning

    Functional recovery is a key goal in treatment of major depressive disorder and schizophrenia. In an...
  • Mental Health 05 Nov, 2021 Read Time: 3 mins
    Congress highlights

    Highlights from ECNP 2021 — Day 3 — October 4th

    Welcome to Progress in Mind’s live coverage of ECNP 2021. This 34th Congress of the European College...
  • Mental Health 05 Nov, 2021 Read Time: 3 mins
    Congress highlights

    Highlights from ECNP 2021 — Day 4 — October 5th

    Welcome to Progress in Mind’s live coverage of ECNP 2021. This 34th Congress of the European College...
  • Mental Health 05 Nov, 2021 Read Time: 3 mins
    Congress highlights

    Highlights from ECNP 2021 — Day 1 — October 2nd

    Welcome to Progress in Mind’s live coverage of ECNP 2021. This 34th Congress of the European College...
  • Mental Health 05 Nov, 2021 Read Time: 4 mins
    Congress highlights

    Highlights from ECNP 2021 — Day 2 — October 3rd

    Welcome to Progress in Mind’s live coverage of ECNP 2021. This 34th Congress of the European College...
  • Bipolar, Schizophrenia 26 Oct, 2021 Read Time: 2 mins
    Congress highlights

    Do similar polygenic risk factors for schizophrenia apply across ethnic groups?

    Polygenic risk factors for schizophrenia and bipolar disorder-- and the genetic factors that...
  • Schizophrenia 04 Oct, 2021 Read Time: 4 mins
    Satellite symposium

    Small steps for big impact in treatment of schizophrenia

    Functional recovery is an important goal in treating schizophrenia, but one that can be hard to...
  • Mental Health 02 Oct, 2021 Read Time: 3 mins
    Congress highlights

    Highlights from ECNP 2021 — Day 4 — October 5th

    Welcome to Progress in Mind’s live coverage of ECNP 2021. This 34th Congress of the European College...
  • Schizophrenia 02 Oct, 2021 Read Time: 4 mins
    Satellite symposium

    Bridging treatment adherence to functional recovery in schizophrenia

    Non-adherence to treatment is a key issue in people with schizophrenia and can hold back response,...
  • Schizophrenia 13 Sep, 2021 Read Time: 3 mins
    Congress highlights

    Cytokine dysregulation in schizophrenia

    Studies continue to indicate a multifaceted relationship between immunological and inflammatory...
  • Mental Health 10 Aug, 2021 Read Time: 3 mins
    Congress highlights

    Pandemic requires comprehensive approach to mental health in the elderly

    Existing psychiatric problems such as depression and anxiety in the elderly should not be forgotten...
  • Schizophrenia 30 Jul, 2021 Read Time: 4 mins
    Congress highlights

    From clinic to community – insights on successful early psychosis management programs

    In the USA, OnTrackNY and the Early Psychosis Intervention NETwork (EPINET) are different parts of a...
  • Schizophrenia 26 Jul, 2021 Read Time: 3 mins
    Congress highlights

    Patients at high risk for psychosis pose a clinical dilemma

    The concept of a clinical high risk syndrome for psychosis is justified not only by the fact that...
  • Schizophrenia 26 Jul, 2021 Read Time: 3 mins
    Congress highlights

    Digital technology may support sustained long-term recovery in first episode psychosis

    Evolving technology can offer people with first episode psychosis personalized treatment when they...
  • Mental Health 26 Jul, 2021 Read Time: 3 mins
    Congress highlights

    Assess outcomes meaningful to patients to improve care equity and quality

    Ensuring that optimum healthcare is open to all - irrespective of gender, ethnicity and social and...
  • Mental Health 26 Jul, 2021 Read Time: 3 mins
    Congress highlights

    Psychosis in dementia or dementia in psychosis? A clinical approach to a common puzzle

    Overlapping and interacting problems of late-life psychosis, depression and cognitive decline –...
  • Mental Health 26 Jul, 2021 Read Time: 3 mins
    Congress highlights

    The pandemic has permanently changed psychiatry, but perhaps not radically

    That was the slightly nuanced overall verdict from the debate. While 93% of the online audience...
  • Schizophrenia 26 Jul, 2021 Read Time: 2 mins
    Congress highlights

    Rethinking ‘persistence’ in negative symptoms for better functional recovery

    Even short-term persistence of negative symptoms is associated with reduced clinical and real-life...
  • Schizophrenia 19 Jul, 2021 Read Time: 2 mins
    Congress highlights

    To screen or not to screen in first-episode psychosis

    There is no international consensus on whether or not to submit those experiencing first-episode...
  • Mental Health 14 Jul, 2021 Read Time: 2 mins
    Congress highlights

    Perspectives on the future of psychiatry: treatment and training

    Prevention, prediction of outcome and precision in therapy emerged as themes at the EPA 2021...
  • Schizophrenia 12 Jul, 2021 Read Time: 5 mins
    Congress highlights

    Intimacy, sexuality and psychosis – breaking the taboo

    Fact: Just likely everyone else, people with mental illness want to experience romance, love and...
  • Schizophrenia 30 Jun, 2021 Read Time: 4 mins
    Congress highlights

    Finding biotypes in psychosis – newer approaches

    It has been known for some time that factors such as longer duration of untreated illness are grossly...
  • Schizophrenia 09 Jun, 2021 Read Time: 4 mins
    Congress highlights

    Psychosis during the COVID19 pandemic – who’s coping?

    The effects of the COVID19 pandemic have impacted everyone to a greater or lesser extent, often with...
  • Schizophrenia 27 Jul, 2020 Read Time: 2 mins
    Congress highlights

    Expert guidance on management of schizophrenia for a better quality of life and independence

    Individualized patient management is key to achieving better lifetime quality of life and...
  • Schizophrenia 22 Jul, 2020 Read Time: 3 mins
    Article

    Digital technology in psychosis – it’s no delusion

    The application of digital interventions is starting to emerge as part of a rapidly expanding cache...
  • Mental Health 20 Jul, 2020 Read Time: 2 mins
    Congress highlights

    Digital lived-experience peer support—a major asset to achieving recovery goals

    Lived-experience peer support often leads to successful engagement of previously difficult-to engage...
  • Schizophrenia 13 Jul, 2020 Read Time: 3 mins
    Article

    Double trouble - managing comorbidity in schizophrenia

    For healthcare workers, overcoming comorbidities in psychotic disorders is rarely straightforward as...
  • Schizophrenia 09 Jul, 2020 Read Time: 3 mins
    Congress highlights

    Early intervention in first-episode psychosis: What works?

    There is a critical period when patients first experience symptoms of psychosis, which may present a...
  • Schizophrenia 08 Jul, 2020 Read Time: 3 mins
    Congress highlights

    Are antipsychotics needed for the long-term treatment of schizophrenia?

    ‘Do we need antipsychotics for the long-term treatment of schizophrenia?’ was the title of this...
  • Schizophrenia 24 May, 2020 Read Time: 1 min
    Interview

    Schizophrenia is a heterogeneous disease with multiple dimensions which can impact functioning

    Schizophrenia is a progressive and recurrent disease with multiple dimensions which can impact the...
  • Schizophrenia 07 May, 2020 Read Time: 3 mins
    Article

    Making sense of exercise in schizophrenia - No sweat!

    Clinicians are well aware that cardiorespiratory fitness and cognition are related in schizophrenia....
  • Schizophrenia 29 Apr, 2020 Read Time: 3 mins
    Article

    Taper or maintain antipsychotics in schizophrenia?

    Taper or maintain? This is a central dilemma surrounding use of antipsychotic medication in patients...
  • Schizophrenia 16 Apr, 2020 Read Time: 3 mins
    Article

    Pandemic brings challenge and opportunity for people with schizophrenia

    The COVID-19 pandemic risks exacerbating symptoms in people prone to experience reality in unusual...
  • Mental Health 06 Apr, 2020 Read Time: 2 mins
    Article

    Practical support for mental health in time of crisis

    Many people with mental health diseases will experience additional emotional distress when faced with...
  • Schizophrenia 23 Mar, 2020

    What is Schizophrenia?

  • Depression, Schizophrenia 19 Mar, 2020 Read Time: 2 mins
    Interview

    Early intervention services have the potential to improve the success of treatment and social functioning for individuals with schizophrenia

    Schizophrenia is a heterogenous, progressive and recurrent disease with multiple dimensions which can...
  • Schizophrenia 10 Mar, 2020

    Improvement in schizophrenia: Long and short term perspectives

  • Schizophrenia 27 Jan, 2020 Read Time: 3 mins
    Article

    The neurobiology of conversion to psychosis – emerging findings from the SHARP study

    The clinical high risk (CHR) phase of schizophrenia when cognitive and social functioning begin to...
  • Schizophrenia 13 Jan, 2020 Read Time: 0 min
    Interview

    John FP Bridges - Changing the paradigm: putting patient treatment goals at the center

  • Schizophrenia 08 Jan, 2020 Read Time: 0 min
    Interview

    John FP Bridges - Aiming for recovery: the world before Schizophrenia

  • Schizophrenia 15 Oct, 2019 Read Time: 3 mins
    Satellite symposium

    Improving treatment outcomes in schizophrenia: Looking beyond positive symptoms for early and effective intervention

    Although the symptoms of schizophrenia are troublesome for almost all persons with the disease, its...
  • Schizophrenia 12 Aug, 2019

    Video #6: Which patients are best suited for long-acting injectable antipsychotics?

  • Schizophrenia 11 Aug, 2019

    Video #5: Early intervention in schizophrenia is key for the long-term prognosis of the disease

  • Schizophrenia 10 Aug, 2019

    Video #4: Discussing the benefit of long-acting injectable antipsychotics with patients and carers

  • Depression, Schizophrenia 09 Aug, 2019

    Video #3: Shared decision-making and therapeutic alliance in schizophrenia

  • Schizophrenia 08 Aug, 2019

    Video #2: Patients at the center

  • Schizophrenia 07 Aug, 2019

    Video #1: Offering long-acting injectable antipsychotics to patients with schizophrenia

  • Schizophrenia 07 Jun, 2019 Read Time: 4 mins
    Congress highlights

    Early intervention for psychosis: Is it worth the investment?

    In a session at WFSBP, chaired by Professor Matcheri Keshavan, Harvard Medical School, Boston, MA,...
  • Schizophrenia, Alcohol Dependence 24 May, 2019 Read Time: 3 mins
    Congress highlights

    Decreasing relapse and rehospitalization in first-episode psychosis

    More than 50% of people with first-episode psychosis (FEP) have comorbid substance use disorder...
  • Mental Health 21 May, 2019 Read Time: 3 mins
    Congress highlights

    What is the role of inflammation in the pathophysiology of mood disorders?

    Evidence supporting a role for inflammation and pro-inflammatory mediators in the pathophysiology and...
  • Mental Health 21 May, 2019 Read Time: 3 mins
    Congress highlights

    A public invitation to view and comment on pre-final APA schizophrenia guideline statements

    Many guidelines exist worldwide on how best to manage psychiatric illnesses, but we never see two...
  • Schizophrenia 16 May, 2019 Read Time: 4 mins
    Congress highlights

    Adherence in the real world

    Non-adherence and lack of engagement commonly mean that patients with serious mental illnesses may...
  • Mental Health 14 May, 2019 Read Time: 3 mins
    Congress highlights

    Challenges for social psychiatry in a changing world

    Modern social risk factors for the development of severe psychiatric disorders, such as migration and...
  • Mental Health 09 May, 2019 Read Time: 4 mins
    Congress highlights

    Social isolation and stigma: Cross-cultural perspectives

    Meaningful connection to other people is as essential to health as the air we breathe. So the stigma...
  • Schizophrenia 02 May, 2019 Read Time: 3 mins
    Congress highlights

    Neuroimaging, antipsychotics and registries – functional capacity

    Neuroimaging studies of response to antipsychotic therapies and glutamate levels in first-episode...
  • Schizophrenia 30 Apr, 2019 Read Time: 4 mins
    Congress highlights

    Enhancing neuroimaging genetics – What do we really see?

    Enhancing neuroimaging genetics through meta-analysis (ENIGMA) does exactly what its expanded acronym...
  • Schizophrenia 15 Apr, 2019 Read Time: 5 mins
    Article

    Ethics of psychosis prevention – Could we? Should we?

    The SIRS Ethics Committee inaugurated the first of its annual symposia at SIRS 2019 to discuss the...
  • Schizophrenia 15 Apr, 2019 Read Time: 4 mins
    Article

    Deconstructing schizophrenia – constructing new paradigms for discovery

    Schizophrenia is a heterogeneous disorder rather than a specific condition, William Carpenter,...
  • Schizophrenia 15 Apr, 2019 Read Time: 3 mins
    Article

    Will the reconceptualization of negative symptoms lead to an effective therapy?

    A recent reconceptualization of the negative symptoms of schizophrenia promises to increase...
  • Mental Health 15 Apr, 2019 Read Time: 4 mins
    Congress highlights

    Psychiatrist and patient partnership encourages trust and effective care

    We have so many shared objectives – notably ensuring adequate resources are given to mental health –...
  • Schizophrenia 15 Apr, 2019 Read Time: 4 mins
    Article

    Early detection and intervention in psychosis – where are we now?

    Many of those experiencing first-episode psychosis achieve clinical remission, but often with poor...
  • Schizophrenia 15 Apr, 2019 Read Time: 3 mins
    Article

    Biomarkers - the Future of Diagnosis in Psychiatry?

    Diagnosis of psychiatric disorders currently depends on clinical criteria. In the future the hope is...
  • Schizophrenia 03 Apr, 2019 Read Time: 4 mins
    Article

    Positive steps to address negative symptoms in schizophrenia

    A goal of precision psychiatry is to locate a patient along the continuum of the disease course,...
  • Schizophrenia 01 Apr, 2019 Read Time: 2 mins
    Article

    Long-acting injectable or oral antipsychotic for first episode psychosis?

    Antipsychotic therapy improves outcomes for patients with first episode of psychosis, yet a study...
  • Schizophrenia 06 Mar, 2019 Read Time: 4 mins
    Article

    The effects of antipsychotic dose reduction/discontinuation on long-term outcome in FEP patients

    Patients with FEP often ask whether they can discontinue their medication after a period of...
  • Schizophrenia 27 Feb, 2019 Read Time: 3 mins
    Article

    Treatment-resistant schizophrenia — mechanisms, awareness, and economic burden

    One-third of individuals with schizophrenia develop treatment-resistant schizophrenia (TRS); and...
  • Schizophrenia 21 Feb, 2019 Read Time: 5 mins
    Article

    Changing the course of schizophrenia: biology, psychology and livelihood

    How to manage and mitigate some long-term problems associated with schizophrenia, and improve...
  • Schizophrenia 12 Feb, 2019 Read Time: 4 mins
    Article

    Complementary approaches for improving outcomes in first-episode psychosis

    Early intervention (EI) services are designed to improve outcomes in patients with first episode...
  • Schizophrenia 07 Feb, 2019 Read Time: 1 min
    Article

    Early use of a long acting injectable antipsychotic shortens hospital stay for acute schizophrenia

    Average hospital stay for patients treated with a long-acting injectable (LAI) antipsychotic...
  • Schizophrenia 23 Jan, 2019 Read Time: 4 mins
    Article

    Use of fidelity scales to ensure and assess high-quality first episode psychosis services

    Fidelity scales ensure that services based on evidence deliver high-quality programs and outcomes,...
  • Mental Health 17 Jan, 2019 Read Time: 3 mins
    Article

    Real-world evidence — raising organizational fluency through interactive learning techniques

    Real-world evidence (RWE) demonstrates long-term effectiveness and safety beyond the efficacy and...
  • Depression, Schizophrenia 09 Jan, 2019 Read Time: 3 mins
    Article

    Brain imaging: focus on predicting disease course and treatment response

    Predicting disease course and predicting response to therapy – including the probability that a...
  • Depression, Schizophrenia 27 Dec, 2018 Read Time: 3 mins
    Article

    ICD-11: new and fit for clinical utility and consistency

    The new ICD chapter on mental health and behavioral disorders is designed to offer guidelines to...
  • Bipolar, Schizophrenia 19 Dec, 2018 Read Time: 3 mins
    Article

    Could therapeutic manipulation of critical periods of brain development benefit mental health?

    Many critical periods of brain development occur during infancy and childhood. When these periods are...
  • Mental Health 17 Dec, 2018 Read Time: 3 mins
    Article

    Train, test, predict: Using big data and machine learning in psychiatry

    Introduction of biomarkers for diagnosis and treatment of psychiatric diseases into routine clinical...
  • Bipolar, Schizophrenia 12 Dec, 2018 Read Time: 3 mins
    Article

    Brain connectivity in early psychosis and during effective antipsychotic therapy

    Resting state functional MRI of the brain is providing fascinating insights into the connectivity...
  • Bipolar, Schizophrenia 03 Dec, 2018 Read Time: 3 mins
    Article

    The OPUS Panel — Sharing lived experiences of mental illness

    A group of young people and their relatives (the OPUS Panel) aims to reduce societal prejudices and...
  • Schizophrenia 28 Nov, 2018 Read Time: 4 mins
    Article

    Improving long-term outcomes in schizophrenia — translating evidence into practice

    The long-term goals of treatment to optimize outcomes for patients with schizophrenia are relapse...
  • Depression, Schizophrenia 21 Nov, 2018 Read Time: 3 mins
    Article

    Inspiring efforts to improve mental health across countries and ages

    Mental ill-health in megacities was the theme for a presidential plenary session at 18th World...
  • Mental Health 14 Nov, 2018 Read Time: 3 mins
    Congress highlights

    Transforming healthcare — the changing landscape of patient engagement

    Patient engagement is the facilitation and strengthening of the role of patients as co-producers of...
  • Mental Health 14 Nov, 2018 Read Time: 3 mins
    Congress highlights

    Early dialogues with patients are informing medicines development

    A 200-strong audience of health economics and outcomes research professionals at ISPOR 2018...
  • Depression, Schizophrenia 12 Nov, 2018 Read Time: 3 mins
    Article

    The evolving science of psychiatry

    Science is beginning to reinforce the practice of psychiatry through increasing understanding of...
  • Bipolar, Schizophrenia 01 Nov, 2018 Read Time: 3 mins
    Article

    Highlighted studies in psychosis

    New light cast on links between mental illness and creativity; inflammatory pathways that may be...
  • Schizophrenia 29 Oct, 2018 Read Time: 4 mins
    Article

    Future of schizophrenia treatment: Where do we go now?

    Over the next decade, the outcomes for patients with schizophrenia should improve considerably,...
  • Schizophrenia 11 Oct, 2018 Read Time: 4 mins
    Congress highlights

    Tackling the elephant in the room: non-adherence in schizophrenia

    The challenges and consequences of non-adherence to treatment in schizophrenia, and some novel ways...
  • Depression, Schizophrenia 09 Oct, 2018 Read Time: 1 min
    Article

    What are you doing to celebrate World Mental Health Day?

    We asked advocacy groups from all around the world why it is important to support World Mental Health...
  • Schizophrenia 09 Oct, 2018 Read Time: 4 mins
    Congress highlights

    Dopamine D2 partial agonists – efficacy, tolerability and improved functioning?

    ‘Functioning’ is a broad term, and encompasses the individual’s ability to perform normal daily...
  • Schizophrenia 27 Sep, 2018 Read Time: 3 mins
    Article

    Treatment-resistant schizophrenia – results of a survey on its clinical impact and therapeutic strategies

    The results of an online survey completed by 204 US psychiatrists on the clinical impact of...
  • Schizophrenia 18 Sep, 2018 Read Time: 4 mins
    Article

    Schizophrenia – from prodrome to psychosis

    Psychosis is preceded by a 3–4 year prodromal phase in 75% of patients, but only 25% of clinical...
  • Depression, Schizophrenia 10 Sep, 2018 Read Time: 1 min
    Interview

    How can you support carers for people with schizophrenia and psychosis?

    More than 25.000 carers have already signed up to The Carer Academy, an interactive online course and...
  • Schizophrenia 01 Aug, 2018 Read Time: 3 mins
    Article

    Steps towards more effective and better tolerated treatment options for schizophrenia

    New more effective and better tolerated treatments for schizophrenia are needed to improve patient...
  • Schizophrenia 11 Jun, 2018 Read Time: 3 mins
    Article

    Effective treatment of schizophrenia requires a patient-centered approach

    Recognition of how people with schizophrenia interact and cope with their experiences is necessary...
  • Schizophrenia 08 May, 2018 Read Time: 4 mins
    Congress highlights

    If one antipsychotic is good, why aren’t two better? Polypharmacy debated

    Increased risk of side effects, reduced compliance, lack of rationale and, above all, no evidence of...
  • Schizophrenia 22 Feb, 2018 Read Time: 3 mins
    Article

    Bouncing back - Resilience in schizophrenia

    Can we improve resilience in patients with schizophrenia to help recovery? Resilience is increasingly...
  • Schizophrenia 09 Jan, 2018 Read Time: 3 mins
    Feature

    Right treatment at right time: Improving outcomes in first episode psychosis

    Integrating evidence-based psychosocial and pharmacological treatments significantly improves the...
  • Bipolar, Schizophrenia 02 Nov, 2017 Read Time: 4 mins
    Article

    Exploring brain connectivity in schizophrenia

    There has been an explosion of interest in research on brain connectivity, across disorders in...
  • Depression, Schizophrenia 13 Sep, 2017 Read Time: 3 mins
    Congress highlights

    Sexual side-effects – let’s talk!

    Sexual side-effects, sometimes experienced by patients during treatment, are not only debilitating...
  • Schizophrenia 04 Sep, 2017 Read Time: 6 mins
    Satellite symposium

    Preventing schizophrenia relapse key to optimizing outcome

    Sustained remission and good functional outcome depend on the interaction between factors we cannot...
  • Schizophrenia 23 May, 2017 Read Time: 1 min
    Event

    World Schizophrenia Day 2017

    EUFAMI speaks about the importance of patient access to treatments that improve Quality of Life and...
  • Mental Health 07 Mar, 2017 Read Time: 8 mins
    Feature

    Genetic and Environmental Impact on Psychiatric and Neurological Disease

  • Schizophrenia 06 Jul, 2016 Read Time: 0 min
    Slide library

    Epidemiology and Burden​

  • Schizophrenia 01 Jun, 2016 Read Time: 4 mins
    Feature

    Schizophrenia across cultures

Most Popular

Progress in Mind Portugal HCP Access verification required

To gain access, please provide details to verify you are a healthcare professional.

If you are not located in Portugal click here.

Continue to verification page Login with email

Brought to you by

 Lundbeck

© 2021

PROGRESS IN MIND PORTUGAL

Cookies

Condições de Utilização

subscribe newsletter

Sign up for newsletter

Register as a health care professional

Login as a registered health care professional

Please enter your email to continue

By submitting this form you agree that your email is sent to a third party for validation.

Read the full terms and conditions here.